Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMIERS: Periodontal Treatment for Stroke Prevention
NCT02541032Phase 3Unknown
- Sponsor
- University of South Carolina
- Start
- Dec 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of minocycline in periodontitis, sponsored by University of South Carolina. Primary endpoint: Composite of Ischemic Stroke, Myocardial Infarction, and Cardiovascular Death at 1 year. Status: unknown.
02
Drugs
minocycline
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT02541032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541032.